![Paroxetine HCl Hemihydrate EP Impurity D ; Paroxetine HCl Hemihydrate BP Impurity D ; Paroxetine HCl Anhydrous EP Impurity D ; Paroxetine HCl USP Related Compound C ; (+)-trans-Paroxetine Hydrochloride ; (3R,4S)-(+)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl)piperidine HCl | 130855-30-0](http://drjcrbio.com/wp-content/themes/shopperpress/thumbs/p-201.png)
Paroxetine HCl Hemihydrate EP Impurity D ; Paroxetine HCl Hemihydrate BP Impurity D ; Paroxetine HCl Anhydrous EP Impurity D ; Paroxetine HCl USP Related Compound C ; (+)-trans-Paroxetine Hydrochloride ; (3R,4S)-(+)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl)piperidine HCl | 130855-30-0
Paroxetine HCl Hemihydrate EP Impurity D
Description
| Code: JCPXT-20 |
| CAS: 130855-30-0 |
| Chemical Formula: C19H21ClFNO3 |
| Molecular Weight: 365.83 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Paroxetine HCl Hemihydrate EP Impurity D ; Paroxetine HCl Hemihydrate BP Impurity D ; Paroxetine HCl Anhydrous EP Impurity D ; Paroxetine HCl USP Related Compound C ; (+)-trans-Paroxetine Hydrochloride ; (3R,4S)-(+)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl)piperidine HCl | 130855-30-0 is useful as reference Impurity standard. |
